CCND1 and metastatic malignant neoplasm in the lymph nodes: Furthermore, CCND1 amplification seems to have great potential as a diagnostic biomarker for lymph node metastasis in a subgroup of clinically nodal negative OSCC although supporting evidence is still not very strong.